Literature DB >> 23588500

Functio laesa: the consequences of the fifth cardinal sign of inflammation in preterm infants.

Laura Bennet1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23588500      PMCID： PMC3634515          DOI： 10.1113/jphysiol.2013.253856

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  7 in total

Review 1.  Chorioamnionitis: a multiorgan disease of the fetus?

Authors:  M Gantert; J V Been; A W D Gavilanes; Y Garnier; L J I Zimmermann; B W Kramer
Journal:  J Perinatol       Date:  2010-10       Impact factor: 2.521

Review 2.  Preterm patent ductus arteriosus: should we treat it?

Authors:  Nick Evans
Journal:  J Paediatr Child Health       Date:  2012-09       Impact factor: 1.954

3.  Disturbance of function (functio laesa): the legendary fifth cardinal sign of inflammation, added by Galen to the four cardinal signs of Celsus.

Authors:  L J Rather
Journal:  Bull N Y Acad Med       Date:  1971-03

Review 4.  Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults.

Authors:  Henrik Hagberg; Pierre Gressens; Carina Mallard
Journal:  Ann Neurol       Date:  2012-02-14       Impact factor: 10.422

Review 5.  Preterm neonatal cardiovascular instability: does understanding the fetus help evaluate the newborn?

Authors:  Laura Bennet; Lindsea C Booth; Paul P Drury; Josine S L Quaedackers; Alistair J Gunn
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-11       Impact factor: 2.557

6.  Intrauterine inflammation alters cardiopulmonary and cerebral haemodynamics at birth in preterm lambs.

Authors:  Robert Galinsky; Stuart B Hooper; Megan J Wallace; Alana J Westover; M Jane Black; Timothy J M Moss; Graeme R Polglase
Journal:  J Physiol       Date:  2013-02-18       Impact factor: 5.182

Review 7.  Effects of chorioamnionitis on the fetal lung.

Authors:  Alan H Jobe
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.